Indogulf Cropsciences / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-02-10Back to IGCL

Revenue

₹116.1 Cr

verified against source

Revenue YoY

17%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 3.9 · Positive source sentiment · 2026-02-10Q3 FY263.93.9
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Indogulf Cropsciences reported Q3 FY26 revenue of ₹116.1 crore, up 17% YoY, driven by strong B2C and B2B execution. PAT grew only 5.6% YoY to ₹3.9 crore due to a one-time prior-period tax adjustment. EBITDA was not disclosed. The 9-month revenue reached ₹553 crore (+19.3% YoY), with PAT up 31% YoY. Growth was broad-based across crop protection (+14%), plant nutrients (+23%), and biologicals (+15%). Subsidiary AGPL contributed ₹54 crore gross sales in 9 months. Management highlighted new export orders from Venezuela, Taiwan, and Sudan (~₹4-5 crore) and expects Q4 and Q1 FY27 demand to improve. Key risk: capacity expansion at Badwasini delayed 2-3 months due to GRAP restrictions, now expected operational by Q1 FY27 end.

Colored figures show movement against the previous available record.

Guidance to track

  • Due to GRAP restrictions, the new facility is delayed by 2-3 months and expected to start by end of Q1 FY27.
  • Abhiprakash Globus will expand into central India with new zonal teams recruited, expected in next few months.
  • Management has shortlisted 4-5 products for launch in Q1 FY27, continuing the pattern of launching in early quarters.

Risks flagged

  • Badwasini plant delayed 2-3 months due to GRAP restrictions in Delhi NCR, now expected Q1 FY27 end.
  • Q3 PAT growth was muted at 5.6% YoY due to a prior-period tax liability settlement; management says it's one-time.
  • Management declined to give quantitative guidance for FY26 or FY27, citing industry uncertainty.

Key quotes

  • We want to speak by our performance and last three quarters have been speaking about Indogulf towards in which direction we are working.
  • Export order margins range from 7% to around 18%.
  • The draft pesticide management bill 2025 and the proposed seed bill 2025 collectively prioritize quality control... which acts as a structural positive for organized large scale players.

Research modules

Go one layer deeper.